tolucombi 80 mg/1 tableta+ 25 mg/1 tableta tableta
krka farma d.o.o. sarajevo - hidrohlorotiazid, телмисартан - tableta - 80 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 80 mg telmisartan 25 mg hidrohlorotiazid
tolucombi 80 mg/1 tableta+ 25 mg/1 tableta tableta
krka farma d.o.o. sarajevo - hidrohlorotiazid, телмисартан - tableta - 80 mg/1 tableta+ 25 mg/1 tableta - 1 tableta sadrži: 80 mg telmisartan 25 mg hidrohlorotiazid
paroxal 20 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - paroksetin - film tableta - 20 mg/1 tableta - 1 film tableta sadrži: 20 mg paroksetin (u obliku paroksetin hidrohlorid hemihidrata)
paroxal 30 mg/1 tableta film tableta
zada pharmaceuticals d.o.o. - paroksetin - film tableta - 30 mg/1 tableta - 1 film tableta sadrži: 30 mg paroksetin (u obliku paroksetin hidrohlorid hemihidrata)
fenesa 200 mg/1 tableta filmom obložena tableta
zentiva pharma d.o.o. - sorafenib - filmom obložena tableta - 200 mg/1 tableta - 1 filmom obložena tableta sadrži: 200 mg sorafeniba (u obliku sorafenib tosilata)
fenesa 200 mg/1 tableta filmom obložena tableta
zentiva pharma d.o.o. - sorafenib - filmom obložena tableta - 200 mg/1 tableta - 1 filmom obložena tableta sadrži: 200 mg sorafeniba (u obliku sorafenib tosilata)
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - drugi gastrointestinalni trakt i metabolizam, lijekovi, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
tabrecta
novartis europharm limited - capmatinib dihydrochloride monohydrate - karcinom, ne-malih stanica pluća - antineoplastična sredstva - tabrecta as monotherapy is indicated for the treatment of adult patients with advanced non small cell lung cancer (nsclc) harbouring alterations leading to mesenchymal epithelial transition factor gene exon 14 (metex14) skipping, who require systemic therapy following prior treatment with immunotherapy and/or platinum based chemotherapy.
zilart 180 mg filmom obložene tablete
makpharm d.o.o., trnjanska cesta 37/1, zagreb, hrvatska - deferasiroks - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 180 mg deferasiroksa
zilart 360 mg filmom obložene tablete
makpharm d.o.o., trnjanska cesta 37/1, zagreb, hrvatska - deferasiroks - filmom obložena tableta - urbroj: jedna filmom obložena tableta sadrži 360 mg deferasiroksa